Publication | Closed Access

Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation

InflammationAnti-inflammatoryAutoimmune DiseaseLupusNrf2 Antioxidant PathwayLupus NephritisImmunologyCell DeathChronic InflammationNlrp3 Inflammasome ActivationAutoimmunityMedicineCell BiologyRheumatoid ArthritisOxidative Stress